Dr. Reddy’s Gets Five U.S. FDA Observations For Hyderabad Plant
Workers pour in raw material to product medicine capsules at Dr Reddy’s plant. (Photographer: Amit Bhargava/Bloomberg News)

Dr. Reddy’s Gets Five U.S. FDA Observations For Hyderabad Plant

Bookmark
Drugmaker Dr. Reddy's Laboratories Ltd. has received five observations from the U.S. health regulator for its active pharmaceutical ingredient plant at Medak in Telangana.The observations are relat...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.